133 related articles for article (PubMed ID: 8446569)
1. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths.
Muller F; Aegerter P; Boue A
Prenat Diagn; 1993 Jan; 13(1):29-43. PubMed ID: 8446569
[TBL] [Abstract][Full Text] [Related]
2. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
[TBL] [Abstract][Full Text] [Related]
3. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
4. Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies.
Blundell G; Ashby JP; Martin C; Shearing CH; Langdale-Brown B; Keeling J; Ellis PM; Shade M; Chambers SE; Wenham PR
Prenat Diagn; 1999 Mar; 19(3):219-23. PubMed ID: 10210119
[TBL] [Abstract][Full Text] [Related]
5. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
[TBL] [Abstract][Full Text] [Related]
6. First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone.
Kratzer PG; Golbus MS; Monroe SE; Finkelstein DE; Taylor RN
Prenat Diagn; 1991 Oct; 11(10):751-63. PubMed ID: 1724801
[TBL] [Abstract][Full Text] [Related]
7. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
[TBL] [Abstract][Full Text] [Related]
9. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
10. First-trimester maternal serum alpha-fetoprotein and human chorionic gonadotropin screening for chromosome defects.
Nebiolo L; Ozturk M; Brambati B; Miller S; Wands J; Milunsky A
Prenat Diagn; 1990 Sep; 10(9):575-81. PubMed ID: 1702539
[TBL] [Abstract][Full Text] [Related]
11. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
13. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
14. Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.
Hayashi M; Kozu H
Prenat Diagn; 1995 Jan; 15(1):11-6. PubMed ID: 7537878
[TBL] [Abstract][Full Text] [Related]
15. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
17. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
18. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
[TBL] [Abstract][Full Text] [Related]
19. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Spencer K
Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Leporrier N; Herrou M; Herlicoviez M; Leymarie P
Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
